Mary Ziping Luo

2020

In 2020, Mary Ziping Luo earned a total compensation of $3M as Chief Operating Officer, Chief Scientist and Chairman at Amphastar Pharmaceuticals, a 1% increase compared to previous year.

Compensation breakdown

Bonus$230,000
Non-Equity Incentive Plan$239,880
Option Awards$890,014
Salary$732,002
Stock Awards$889,988
Other$24,910
Total$3,006,794

Luo received $890K in option awards, accounting for 30% of the total pay in 2020.

Luo also received $230K in bonus, $239.9K in non-equity incentive plan, $732K in salary, $890K in stock awards and $24.9K in other compensation.

Rankings

In 2020, Mary Ziping Luo's compensation ranked 3,835th out of 13,090 executives tracked by ExecPay. In other words, Luo earned more than 70.7% of executives.

ClassificationRankingPercentile
All
3,835
out of 13,090
71st
Division
Manufacturing
1,527
out of 5,620
73rd
Major group
Chemicals And Allied Products
577
out of 2,253
74th
Industry group
Drugs
496
out of 1,953
75th
Industry
Pharmaceutical Preparations
375
out of 1,458
74th

Pay ratio

Mary Ziping Luo's Pay$3,006,794
Median Employee's Pay$46,374
Pay Ratio

65

to 1

In 2020, the annual total compensation of Mary Ziping Luo was $3,006,794.

The annual total compensation of the median employee at Amphastar Pharmaceuticals was $46,374.

The ratio of Mary Ziping Luo's pay to the pay of median employee was therefore 65 to one.

Source: SEC filing on April 14, 2021.

Luo's colleagues

We found five more compensation records of executives who worked with Mary Ziping Luo at Amphastar Pharmaceuticals in 2020.

2020

Jason Shandell

Amphastar Pharmaceuticals

General Counsel

2020

Jack Zhang

Amphastar Pharmaceuticals

Chief Executive Officer

2020

William Peters

Amphastar Pharmaceuticals

Chief Financial Officer

2020

Rong Zhou

Amphastar Pharmaceuticals

Executive Vice President of Production and President of Armstrong Pharmaceuticals, Inc

2020

Jacob Liawatidewi

Amphastar Pharmaceuticals

Executive Vice President of Sales and Marketing, Executive Vice President of Corporate Administration Center and President of Amphastar France Pharmaceuticals, S.A.S

News

You may also like